Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick^™ dry-powder inhaler in the treatment of asthma

JOURNAL ARTICLE published 1 September 2016 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Michael J. Welch

An update on the safety and efficacy of regorafenib in the treatment of solid cancers

JOURNAL ARTICLE published November 2014 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Stephen L Chan | Brigette BY Ma

JOURNAL ISSUE published June 2007 in Expert Opinion on Drug Metabolism & Toxicology

Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure

JOURNAL ARTICLE published 2 July 2020 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Megan K Young | Shu-Kay Ng | Graeme R Nimmo | Allan W Cripps

Rosiglitazone in Canada: experience in clinical practice

JOURNAL ARTICLE published April 2009 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Beata Patasi | Deborah MacNair | Ryan J Marble | J Robin Conway

PK evaluation of fondaparinux sodium for the treatment of thrombosis

JOURNAL ARTICLE published February 2014 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Xavier Delavenne | Paul Frappé | Paul Zufferey | Patrick Mismetti | Silvy Laporte | Laurent Bertoletti

Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancer

JOURNAL ARTICLE published 1 February 2019 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Marie Robert | Jean-Sébastien Frenel | Emmanuelle Bourbouloux | Dominique Berton Rigaud | Anne Patsouris | Paule Augereau | Carole Gourmelon | Mario Campone

In vitrodrug metabolism testing using blood-monocyte derivatives

JOURNAL ARTICLE published December 2013 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Guillermo Gómez-Icazbalceta | Ignacio González-Sánchez | José Moreno | Marco A Cerbón | Alicia Cervantes

Cross-species comparative toxicogenomics as an aid to safety assessment

JOURNAL ARTICLE published December 2006 in Expert Opinion on Drug Metabolism & Toxicology

Authors: William B Mattes

Pharmacokinetic and pharmacodynamic considerations on the erythropoietin effect and adverse events of darbepoetin

JOURNAL ARTICLE published 2 January 2015 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Frieder Keller | Ulla Ludwig | David Czock

A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer’s disease

JOURNAL ARTICLE published February 2007 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Frederick Schmitt | Melody Ryan | Gregory Cooper

Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus

JOURNAL ARTICLE published October 2006 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Chantal Mathieu

Pharmacokinetics and pharmacodynamics of incobotulinumtoxinA influencing the clinical efficacy in post-stroke spasticity

JOURNAL ARTICLE published 2 April 2016 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Kirsten E. Zeuner | Günther Deuschl

The role of CYP26 enzymes in retinoic acid clearance

JOURNAL ARTICLE published August 2009 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Jayne E Thatcher | Nina Isoherranen

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

JOURNAL ARTICLE published November 2012 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Anna Korycka-Wołowiec | Tadeusz Robak

Pharmacokinetic evaluation of losartan

JOURNAL ARTICLE published May 2011 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Michel Burnier | Grégoire Wuerzner

Pharmacokinetics of new oral hepatitis C antiviral drugs

JOURNAL ARTICLE published January 2013 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Eugenia Vispo | Pablo Barreiro | Vicente Soriano

An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria

JOURNAL ARTICLE published 2 January 2022 in Expert Opinion on Drug Metabolism & Toxicology

Research funded by Conselho Nacional de Desenvolvimento Científico e Tecnológico (404067/2012-3 and 2020/00433-8) | European and Developing Countries Clinical Trials Partnership (RIA2017T-2018) | Fundação de Amparo *a Pesquisa do Estado de mInas Gerais (CBB-APQ 00952-16)

Authors: Leyre Pernaute-Lau | Mahamadou Camara | Taís Nóbrega de Sousa | Ulrika Morris | Marcelo Urbano Ferreira | José Pedro Gil

Allopurinol: insights from studies of dose–response relationships

JOURNAL ARTICLE published 3 April 2017 in Expert Opinion on Drug Metabolism & Toxicology

Research funded by National Health and Medical Research Council (1054146)

Authors: Richard O. Day | Diluk R.W. Kannangara | Sophie L. Stocker | Jane E. Carland | Kenneth M. Williams | Garry G. Graham

Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis

JOURNAL ARTICLE published 2 November 2019 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Anna Campanati | Matteo Paolinelli | Frederico Diotallevi | Emanuela Martina | Elisa Molinelli | Annamaria Offidani